πŸŽ‰ Pharmidex at Olink’s Lunchtime Networking Event! πŸŽ‰
February 4, 2025

We are delighted to announce that Martin Barrett, Head of Business Development at Pharmidex, will be attending the Lunchtime Networking Event – Olink PEA Technology Transforming Healthcare:

"The Impact of Proteogenomics" today, February 4, 2025, at Bee House, Milton, Abingdon, UK.


This event is a fantastic opportunity to explore how proteogenomics is shaping the future of healthcare and drug discovery. 

Martin looks forward to meeting fellow professionals, exchanging insights, and expanding Pharmidex’s network to support innovation in drug development.


πŸ“ Event Details:

πŸ—“ Date: February 4, 2025

πŸ“Œ Location: Bee House, 140 Eastern Ave, Park Dr, Milton, Abingdon OX14 4SB


If you're attending, don’t hesitate to connect with Martin and discover how Pharmidex can help accelerate your drug discovery and development success!

#Pharmidex #Networking #Olink #Proteogenomics #DrugDiscovery #Innovation #Collaboration


? Pharmidex is proud to sponsor CamMedChem’25! ?
September 12, 2025
We’re delighted to announce that Pharmidex will be an official sponsor of CamMedChem’25 , the renowned meeting organized by the Royal Society of Chemistry’s Biomolecular Chemistry Special Interest Group This year’s theme promises cutting-edge discussions in medicinal chemistry, biomolecular interactions and the latest trends in small molecule and chemical biology research. We’re honoured to support such a pivotal forum for scientists, drug discovery experts and academic innovators to exchange ideas, foster collaborations, and advance therapeutic discovery. πŸ‘‰ We look forward to: Learning from the powerful scientific insights shared at the meeting Exploring new partnerships that further the translation of biomolecular science into impactful therapies We can’t wait to see you in Cambridge for CamMedChem’25!
Pharmidex Histology Services: Precision You Can Trust
September 8, 2025
At Pharmidex , we deliver comprehensive histology solutions designed to support preclinical and clinical research with accuracy and reliability. πŸ”¬ From sample to slide, our services include: tissue processing, embedding, microtomy, routine and special staining, digital imaging and slide scanning all underpinned by rigorous quality control and expert scientific oversight. With specialist capabilities and high-throughput workflows, we help researchers generate high-quality, reproducible data across toxicology, oncology, CNS and beyond. πŸ‘‰ Learn more: pharmidex.com/histology
? Expanding our integrated capabilities in autoimmune research
September 3, 2025
At Pharmidex , we are proud to offer a comprehensive preclinical platform for autoimmune disease research. Using in vivo EAE models, we combine: βœ”οΈ Bioanalysis & biomarker profiling to quantify key cytokines and mediators of disease progression βœ”οΈ Histological assessment, enabling detailed evaluation of inflammation, demyelination and tissue pathology across multiple organs βœ”οΈ Pharmacological intervention studies, including established treatments such as Fingolimod for validation This integrated approach delivers a complete and translationally relevant dataset, supporting drug discovery and development programmes from mechanistic insight through to therapeutic evaluation. By combining in vivo efficacy, biomarker analysis and histology, our team provides partners with a more comprehensive understanding of disease mechanisms and treatment effects. πŸ‘‰ Learn more about our services in Histology, Biomarker Analysis, and Autoimmune Disease Models.
More Posts